Impact of triiodothyronine on the survival of high-risk patients undergoing open heart surgery

Cardiology (Switzerland)

Volumn 87, Issue 6, 1996, Pages 509-515

  Novitzky, Dimitri ^a   Fontanet, Hector ^b   Snyder, Michael ^c   Coblio, Nicholas ^c   Smith, Daniel ^b   Parsonnet, Victor ^d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Cardiopulmonary bypass; Triiodothyronine

Indexed keywords

ADRENALIN; GLYCERYL TRINITRATE; INOTROPIC AGENT; LIOTHYRONINE; NITROPRUSSIDE SODIUM;

ADULT; AGED; AORTA CLAMPING; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; DISCRIMINANT ANALYSIS; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FORWARD HEART FAILURE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL DISEASE; OPEN HEART SURGERY; PRIORITY JOURNAL; SURGICAL MORTALITY; SURVIVAL RATE;

EID: 0029758971     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177147     Document Type: Article

References (49)

1. Grover F. Johnson R, Marshall G, Hammer-meistcr KE: Factors predictive of operative mortality among coronary artery bypass subsets. Ann Thorac Surg 1993:56:1-11.
2. Hammermeister KE, Burchfiel C. Johnson R, Grover FL: Identification of patients at greatest risk for developing major complications at cardiac surgery. Circulation 1990;82:380-389.
3. Grover FL. Hammermeister KE. Burchfiel C. Cardiac Surgeons of the Dept, of Veterans Affairs: Initial report of the veterans administration preoperative risk assessment study for cardiac surgery. Ann Thorac Surg 1990:50:12-28.
4. Clark RE: The Society of Thoracic Surgeons National Data Base Status Report. Ann Thorac Surg 1993:57:27-32.
5. Edwards ED. Clark RE. Schwartz M: Coronary artery bypass grafting: The Society of Thoracic Surgeons National Data Base Experience. Ann Thorac Surg 1994:57:20-26.
6. Parsonnet V, Dean D, Burstein AD: A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease.Circulation 1988(suppl 1);79:3-12.
7. Hearse DJ: Stunning: A radical review. Car-diovasc Drugs Ther 1991;5:853-876.
8. Keith A, Fox A. Bcrgmann SR. Sobct BE: Pathophysiology of myocardial reperfusion. Annu Rev Med 1985:36:125-144.
9. Kukiclka GL. Hawkins KH. Michael L. Manning AM. Youker K. Lane C, Entman ML. Smith CW. Anderson DC: Regulation of intercellular adhesion molecule-! (ICAMOl) in ischemic and reperfused canine myocardium. J Clin Invest 1993:92:1504-1516.
10. Edmunds LH: Systemic inflammatory responses secondary to cardiopulmonary bypass. Am J Surg 1993(CME suppl):4-9.
11. Robuschi G. Medici D. Fcsani F. Barboso G. Montcrmini M. d'Amato L. Gardini E. Bor-ciani E, Dalf Aglio F. Salvi M: Cardiopulmonary bypass: A low Tj and T3 syndrome with blunted thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH). Horm Res 1986;23:151-158.
12. Clark RE: Thyroid and other endocrine responses to cardiopulmonary bypass. Am J Surg 1993(CME suppl): 10-14.
13. Wartofsky L. Burman KD: Alterations in thyroid function in patients with systemic illness: The ‘euthyroid sick syndrome'. Endocr Rev 1982;3:164-217.
14. Slag MF. Morley JE, Elson MK: Hypothyroxi-nemia in critically ill patients as a predictor of high mortality. JAMA 1981:245:43-45.
15. Hamilton MA: Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure. Ann Thorac Surg 1993;56:548-553.
16. Novitzky D, Wicomb WN, Cooper DKC. Frazer R. Barnard CN: Electrocardiographic hemodynamic and endocrine changes occurring during experimental brain death in the Chac-ma baboon. Heart Transplant 1984:4:63.
17. Novitzky D, Copper D. Reichart B: Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987:43:852-854.
18. Novitzky D. Cooper D. Chaffin J. Greer AE, DeBault LE. Zuhdi N: Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990:49:311-316.
19. Novitzky D. Matthews N. Shawley D. Cooper DKC. Zuhdi N: Triiodothyronine in the recovery of stunned myocardium in dogs. Ann Tho-racSurg 1991:51:10-17.
20. Yokoyama Y. Novitkv D. Deal MT. Snow TR: Facilitated recovery of cardiac performance by triiodothyronine following a transient ischemic insult. Cardiology 1992:81:34-35.
21. Novitzky D. Human P. Cooper D: Inotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: An experimental study in pigs. Ann Thorac Surg 1988;45:50-55.
22. Novitzky D. Human P. Cooper D: Effect of triiodothyronine TO on myocardial high energy phosphates and lactate after ischemia and cardiopulmonary bypass. J Thorac Cardiovasc Sutg 1988:96:600-607.
23. Novitzky D. Cooper DKC. Swanepoel A: Inotropic effect of triiodothyronine TO in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: Initial experience in patients undergoing open heart surgery. Eur J Cardiothorac Surg 1989:3:140-145.
24. Novitzky D. Cooper D. Barton I. Greer A, Chaffin J. Grim J. Zuhdi N: Triiodothyronine as an inotropic agent alter open heart surgery. J Thorac Cardiovasc Surg 1989:98:972-978.
25. Pienaar H. Schwartz L, Ronconc A. Lotz Z. Hickman R: Function of kidney grafts from brain-dead donor pigs. The influence of dopamine and triiodothyronine. Transplantation 1990:50:580-582.
26. Rudinger A. Myloltc K. Davis P. Davis F. Bias S: Rabbit myocardial membrane Ca2+ adenosine triphosphatase activity: Stimulation in vitro by thyroid hormone. Biochem Biophys 1984:229:379-385.
27. Davis PJ: Cellular actions of thyroid hormones; in Braverman LE, Utinger RD (eds): Werner and Ingbar's the Thyroid, cd 6. Philadelphia. 1991.
28. Ginsbert AM. Clutter WE. Shah SD, Cryer PE: Triiodothyronine-induced thyrotoxicosis increases mononuclear leukocyte beta-adrenergic receptor density in man. J Clin Invest 1981:67: 1785-1791.
29. Segal J: Action of the thyroid hormone at the level of the plasma membrane. Endocr Res 1989:15:619-649.
30. Rudinger A, Mylotte KM, Davis PJ, Davis FB. Bias SD: Rabbit myocardial membrane Ca2+ ATPasc activity: Stimulation in vitro by thyroid hormone. Arch Biochem Biophys 1984: 229:379-385.
31. Segal J: In vivo effect 3.5.3'-triiodothyroninc on calcium uptake in several tissues in the rat: Evidence for a physiologic role for calcium as the first messenger for the prompt action of thyroid hormone at the level of the plasma membrane. Endocrinology 1990:127:17-24.
32. Kim D. Smith T: Effects of thyroid hormone on calcium handling in cultured chick ventricular cells. J Physiol (Lond) 1985:364:131-149.
33. 2*-ATPase activity: Stimulation in vitro by thyroid hormone analogues and bipyridines. Bio-chim Biophys Acta 1993; 115:184-190.
34. 2*-ATPase of sarcoplasmic reticulum that affect functional association with phos-pholamban. J Biol Chem 1993:268(4):2809-2815.
35. Krause SM. Jacobus WE. Becker LC: Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischemic 'stunned' myocardium. Circ Res 1989;65:526-530.
36. Sterling K: Direct thyroid hormone activation of mitochondria: The role of adenine nucleotide translocase. Endocrinology 1986:119:292-295.
37. Davis PJ: Cellular actions of thyroid hormones: in Braverman LE, Utinger RD (eds): Warner and Ingbar's the Thyroid, ed 6. Philadelphia. 1991.
38. Hoh JFY. McGrath PA. Hale PT: Electrophoretic analysis of multiple forms of cardiac myosin: Effect of hypophysectomy and thyroxine replacement. J Mol Cell Cardiol 1978; 10: 1053-1076.
39. Snow TR. Deal MT, Connelly TS, Yokoyama Y, Novitzky D: Acute inotropic response to rabbit papillary muscle to triiodothvronine. Cardiology 1992:80:112-117.
40. Dyke CM. Yeh T. Lehman JD, Abd-Elpattah A, Ding M. Wechslcr AS: Triiodothyronine-enhanced left ventricular function after ischemia injury. Ann Thorac Surg 1991;52:14-19.
41. Dyke CM, Ding M. Abd-Elfattah AS, Loesser K. Dignan RJ. Wechslcr AS. Salter DR: Effects of triiodothyronine supplementation after myocardial ischemia. Ann Thorac Surg 1993; 56:215-222.
42. Taniguchi S. Kitamuras S. Kawachi K. Doi Y. Aoyama N: Effects of hormonal supplements on the maintenance of cardiac function in potential donor patients after cerebral death. Eur J Cardiothorac Surg 1992:6:96.
43. Orlowski JP. Spees EK: Improved cardiac transplant survival with thyroxine treatment of hcmodynamically unstable donors: 95.2% graft survival at 6 and 30 months. Transplant Proc 1993:25:1535.
44. Novitzky D, Wicomb WN. Cooper DKC. Tjaalgard MA: Improved cardiac function following hormonal therapy in brain-dead pigs: Relevance to organ donation. Cryobiology 1987;24:1-10.
45. Novitzky D. Cooper DKC. Chaffin JS. Greer AE. Debault LE. Zuhdi N: Improved cardiac allograft function following triiodothyronine TO therapy to both donor and recipient. Transplantation 1990:49:311-316.
46. Klein I: Thyroid hormone and the cardiovascular system. Am J Med 1990;88:631-637.
47. Dulchavskv SA. Lucas CE. Ledgcwood AM. Grabow D: Triiodothyronine TO improves CV fanction during hemorrhagic shock. Circ Shock 1993;39:67-73.
48. Klein I: Treatment of myxedema-associated cardiogenic shock. Ann Intern Med 1993:119: 168-169.
49. Hesch RD, Husch M, Kodding R. Hoffken B. Mayer T: Treatment of dopamine-dependent shock with T3. Endocr Res Commun 1981:8: 229-237.